Giulio Cerea

2.0k total citations
34 papers, 533 citations indexed

About

Giulio Cerea is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Giulio Cerea has authored 34 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Giulio Cerea's work include Lung Cancer Treatments and Mutations (18 papers), Colorectal Cancer Treatments and Studies (8 papers) and Lung Cancer Research Studies (7 papers). Giulio Cerea is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Colorectal Cancer Treatments and Studies (8 papers) and Lung Cancer Research Studies (7 papers). Giulio Cerea collaborates with scholars based in Italy, United States and Singapore. Giulio Cerea's co-authors include Salvatore Siena, Andrea Sartore‐Bianchi, Paolo Lissoni, Massimo Vaghi, A Ardizzoia, R Bucovec, Gabriele Tancini, S. Villà, G Gardani and Laura Giannetta and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Giulio Cerea

34 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giulio Cerea Italy	15	277	234	174	83	61	34	533
Hui‐Jen Tsai Taiwan	16	220 0.8×	75 0.3×	130 0.7×	79 1.0×	77 1.3×	53	581
Yifang Zhu China	11	177 0.6×	231 1.0×	265 1.5×	162 2.0×	60 1.0×	24	540
Somesh Chattopadhyay United States	6	140 0.5×	76 0.3×	131 0.8×	64 0.8×	51 0.8×	9	430
J. Tillner Germany	14	423 1.5×	272 1.2×	243 1.4×	25 0.3×	32 0.5×	29	880
Akihiko Kidani Japan	12	213 0.8×	104 0.4×	428 2.5×	113 1.4×	26 0.4×	20	684
Juan M. Jiménez‐Vacas Spain	16	97 0.4×	181 0.8×	461 2.6×	230 2.8×	21 0.3×	32	712
Fang Xie China	15	133 0.5×	85 0.4×	215 1.2×	86 1.0×	24 0.4×	76	596
B Neri Italy	15	233 0.8×	200 0.9×	104 0.6×	59 0.7×	29 0.5×	46	627

Countries citing papers authored by Giulio Cerea

Since Specialization

Citations

This map shows the geographic impact of Giulio Cerea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulio Cerea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulio Cerea more than expected).

Fields of papers citing papers by Giulio Cerea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulio Cerea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulio Cerea. The network helps show where Giulio Cerea may publish in the future.

Co-authorship network of co-authors of Giulio Cerea

This figure shows the co-authorship network connecting the top 25 collaborators of Giulio Cerea. A scholar is included among the top collaborators of Giulio Cerea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulio Cerea. Giulio Cerea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marando, Alessandro, Emanuele Valtorta, Calogero Lauricella, et al.. (2024). Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature. Pathologica. 116(1). 13–21. 1 indexed citations

Ceresoli, Giovanni Luca, Giulio Rossi, Francesco Agustoni, et al.. (2024). Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach. Critical Reviews in Oncology/Hematology. 199. 104247–104247. 1 indexed citations

Pizzutilo, Elio Gregory, Valentina Motta, Calogero Lauricella, et al.. (2023). Repotrectinib Overcomes F2004V Resistance Mutation in ROS1-Rearranged NSCLC: A Case Report. JTO Clinical and Research Reports. 4(11). 100555–100555. 5 indexed citations

Pizzutilo, Elio Gregory, Laura Giannetta, Giulio Cerea, et al.. (2023). Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity. Cancer Research. 83(14). 2283–2296. 9 indexed citations

Patelli, Giorgio, Federica Tosi, Gianluca Mauri, et al.. (2021). Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA. Targeted Oncology. 16(3). 309–324. 23 indexed citations

Patelli, Giorgio, Katia Bencardino, Federica Tosi, et al.. (2021). Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literature. Journal of Medical Case Reports. 15(1). 32–32. 1 indexed citations

Patelli, Giorgio, Federica Tosi, Gianluca Mauri, et al.. (2021). Correction to: Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA. Targeted Oncology. 16(3). 413–413. 2 indexed citations

Pizzutilo, Elio Gregory, Alessio Amatu, Lorenzo Ruggieri, et al.. (2021). Liquid Biopsy for Small Cell Lung Cancer either De Novo or Transformed: Systematic Review of Different Applications and Meta-Analysis. Cancers. 13(9). 2265–2265. 20 indexed citations

Schram, Alison M., Alexander Drilon, Teresa Macarulla, et al.. (2020). A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumors.. Journal of Clinical Oncology. 38(15_suppl). TPS3654–TPS3654. 17 indexed citations

10.

Sartore‐Bianchi, Andrea, Elio Gregory Pizzutilo, Giovanna Marrapese, et al.. (2020). Entrectinib for the treatment of metastatic NSCLC: safety and efficacy. Expert Review of Anticancer Therapy. 20(5). 333–341. 28 indexed citations

11.

Cappuzzo, Federico, Alessandro Morabito, Nicola Normanno, et al.. (2016). Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer. Lung Cancer. 99. 31–37. 30 indexed citations

12.

Ammirati, Enrico, Michela Brambatti, Francesca Spanò, et al.. (2015). Eosinophilic myocarditis: a paraneoplastic event. The Lancet. 385(9986). 2546–2546. 19 indexed citations

13.

Gridelli, Cesare, Silvia Novello, Nicoletta Zilembo, et al.. (2014). Phase II Randomized Study of Vandetanib Plus Gemcitabine or Gemcitabine Plus Placebo as First-Line Treatment of Advanced Non–Small-Cell Lung Cancer in Elderly Patients. Journal of Thoracic Oncology. 9(5). 733–737. 28 indexed citations

14.

Braud, Filippo de, Lorenzo Pilla, Monica Niger, et al.. (2014). Rxdx-101, an Oral Pan-Trk, Ros1, and Alk Inhibitor, in Patients with Advanced Solid Tumors with Relevant Molecular Alterations. Annals of Oncology. 25. iv148–iv148. 7 indexed citations

15.

Gridelli, Cesare, Floriana Morgillo, Adolfo Favaretto, et al.. (2011). Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study. Annals of Oncology. 22(7). 1528–1534. 44 indexed citations

16.

Capri, Stefano, Alessandro Morabito, Guido Carillio, et al.. (2007). Valutazione economica di erlotinib, docetaxel e pemetrexed nel trattamento di seconda linea del carcinoma polmonare non a piccole cellule. 9(2). 113–124. 8 indexed citations

17.

Sartore‐Bianchi, Andrea, et al.. (2007). Rationale and Clinical Results of Multi-target Treatments in Oncology. The International Journal of Biological Markers. 22(1_suppl4). 77–87. 15 indexed citations

18.

Sartore‐Bianchi, Andrea, Giulio Cerea, Laura Giannetta, et al.. (2006). Anti-EGFR monoclonal antibodies in the treatment of non-small cell lung cancer. Annals of Oncology. 17. ii49–ii51. 4 indexed citations

19.

Artale, Salvatore, Laura Giannetta, Giulio Cerea, et al.. (2005). Treatment of metastatic neuroendocrine carcinomas based on WHO classification. Anticancer Res. 7 indexed citations

20.

Cerea, Giulio, Massimo Vaghi, A Ardizzoia, et al.. (2003). Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.. PubMed. 23(2C). 1951–4. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hui‐Jen Tsai Breakdown of academic impact, for papers by Yifang Zhu Breakdown of academic impact, for papers by Somesh Chattopadhyay Breakdown of academic impact, for papers by J. Tillner Breakdown of academic impact, for papers by Akihiko Kidani Breakdown of academic impact, for papers by Juan M. Jiménez‐Vacas Breakdown of academic impact, for papers by Fang Xie Breakdown of academic impact, for papers by B Neri